35.7 C
Bangkok
Friday, March 29, 2024

Avivagen Inc. Announces Results for the First Quarter Ending January 31, 2021

OTTAWA, Ontario–()–Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that enhance feed intake and safely support immune function, thereby supporting general health and performance, has announced its unaudited financial results for the first quarter of 2021. Unless otherwise noted, all figures are in Canadian currency.

Milestones achieved during Q1 2021 include:

  • Secured sizeable recurring order (6 tonne total at 500kg/month) with Transformadora Agricola de Alimentos S.A. de C.V in Mexico. Product will begin shipping to the customer in April, 2021.
  • Finalized shipping arrangements for previously announced 10 tonne order with Industrias Melder in Mexico.

    • Product to be shipped commencing Q2,…

Read more…

Latest Articles